Assessing venous thromboembolism risk in lung cancer: a comprehensive evaluation of the khorana score, clinical characteristics, and incidence of thrombosis

IntroductionVenous thromboembolism (VTE) occurrence in patients with lung cancer is associated with significant morbidity and mortality. The Khorana Score (KRS) is a validated risk stratification tool developed to estimate risk of VTE in patients with cancer that incorporates clinical and laboratory...

Description complète

Détails bibliographiques

Auteurs principaux:	Sean C. Dougherty, Rishika Singh, Caleb McKinney, Aditya Singh, Jack Masur, Alia C. Lynch, Ryan D. Gentzler, Wendy Novicoff, Nathan Roberts, Richard D. Hall
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2026-01-01
Collection:	Frontiers in Oncology
Sujets:	khorana risk score non-small cell lung cancer oncogenic driver mutation small cell lung cancer venous thromboembolism
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1651192/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!